Maze Therapeutics MAZE
$31.37 −$1.06 (-3.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $31.37 0.00%
Open$31.77
Prev close$32.43
Day range$30.88 – $32.80
Volume818.9K
Market cap$1.72B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$51.52M-56.3% YoY
Net profit-$47.97M-59.4% YoY
Diluted EPS-$0.79-19.7% YoY
Free cash flow-$33.13M-34.1% YoY
Operating cash flow-$32.84M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Operating margin-820.8%
Net margin-757.4%
Return on equity-37.5%
Return on assets-32.4%
Return on invested capital-37.4%
Current ratio14.14
Liabilities / assets16.2%
Cash & investments$389.66M
Total debt$54.71M
Net cash (debt)$334.95M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $0.00 | $0.00 | $20.00M | $0.00 | $0.00 |
| Total Operating Revenue | $0.00 | $0.00 | $20.00M | $0.00 | $0.00 |
| Operating Expense | $51.52M | $48.04M | $46.55M | $142.90M | $38.06M |
| Selling and Admin Expenses | $11.30M | $13.10M | $12.41M | $34.45M | $10.49M |
| -General & Admin Expense | $11.30M | $13.10M | $12.41M | $34.45M | $10.49M |
| Research & Development | $40.22M | $34.94M | $34.15M | $108.45M | $27.57M |
| Operating Profit | -$51.52M | -$48.04M | -$26.55M | -$142.90M | -$38.06M |
| Net Non-Operating Interest Income (Expense) | $3.55M | $3.31M | $2.35M | $11.78M | $3.49M |
| Non-Operating Interest Income | $4.52M | $4.24M | $3.21M | $11.78M | $3.49M |
| Non-Operating Interest Expense | $975,000.00 | $931,000.00 | $866,000.00 | – | – |
| Pretax Profit | -$47.97M | -$44.73M | -$24.21M | -$131.12M | -$34.57M |
| Net Profit | -$47.97M | -$44.73M | -$24.21M | -$131.12M | -$34.57M |
| Profit from Continuing Operations | -$47.97M | -$44.73M | -$24.21M | -$131.12M | -$34.57M |
| Net Income to Parent Company | -$47.97M | -$44.73M | -$24.21M | -$131.12M | -$34.57M |
| Net Income to Common Stockholders | -$47.97M | -$44.73M | -$24.21M | -$131.12M | -$34.57M |
| Basic EPS | -$0.79 | -$0.76 | -$0.45 | -$3.05 | -$0.65 |
| Diluted EPS | -$0.79 | -$0.76 | -$0.45 | -$3.05 | -$0.65 |
| Tax | – | – | – | $0.00 | $0.00 |
| Other Preferred Stock Dividends | – | – | – | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $511.56M | $531.63M | $419.71M | $397.13M | $397.13M |
| Total Current Assets | $400.10M | $420.42M | $379.78M | $349.72M | $349.72M |
| Cash and Cash Equivalents & Short-Term Investments | $389.66M | $411.09M | $352.38M | $341.92M | $341.92M |
| -Cash and Cash Equivalents | $154.16M | $202.64M | $198.77M | $189.25M | $189.25M |
| -Short Term Investments | $235.50M | $208.44M | $153.62M | $152.67M | $152.67M |
| Other Current Assets | $10.44M | $9.34M | $7.40M | $7.80M | $7.80M |
| Total Non-Current Assets | $111.46M | $111.20M | $39.93M | $47.41M | $47.41M |
| Net PPE | $21.94M | $22.83M | $23.97M | $25.16M | $25.16M |
| -Gross PPE | $21.94M | $22.83M | $23.97M | $44.37M | $44.37M |
| Investments and Advances | $87.32M | $83.82M | $10.56M | $18.11M | $18.11M |
| -Available for Sale Securities | $87.32M | $83.82M | $10.56M | $18.11M | $18.11M |
| Other Non-Current Assets | $2.19M | $4.55M | $5.41M | $4.14M | $4.14M |
| Total Liabilities | $83.01M | $78.50M | $78.01M | $42.16M | $42.16M |
| Total Current Liabilities | $28.30M | $22.96M | $21.24M | $22.56M | $22.56M |
| Payables | $4.57M | $2.21M | $4.01M | $1.79M | $1.79M |
| -Accounts Payable | $4.57M | $2.21M | $4.01M | $1.79M | $1.79M |
| Current Accrued Expenses | $9.06M | $8.94M | $6.97M | $5.11M | $5.11M |
| Short-Term Debt and Capital Lease Obligation | $4.93M | $4.88M | $4.84M | $4.80M | $4.80M |
| -Current Capital Lease Obligation | $4.93M | $4.88M | $4.84M | $4.80M | $4.80M |
| Total Non-Current Liabilities | $54.71M | $55.54M | $56.77M | $19.61M | $19.61M |
| Long Term Debt and Capital Lease Obligation | $54.71M | $55.54M | $56.39M | $18.51M | $18.51M |
| -Long Term Debt | $39.12M | $38.96M | $38.83M | – | – |
| -Long Term Capital Lease Obligation | $15.59M | $16.58M | $17.55M | $18.51M | $18.51M |
| Total Equity | $428.55M | $453.12M | $341.70M | $354.97M | $354.97M |
| Stockholders' Equity | $428.55M | $453.12M | $341.70M | $354.97M | $354.97M |
| Capital Stock | $56,000.00 | $56,000.00 | $50,000.00 | $49,000.00 | $49,000.00 |
| -Common Stock | $56,000.00 | $56,000.00 | $50,000.00 | $49,000.00 | $49,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.04B | $1.01B | $855.54M | $844.35M | $844.35M |
| Retained Earnings | -$606.45M | -$558.48M | -$513.76M | -$489.55M | -$489.55M |
| Gains/Losses Not Affecting Retained Earnings | -$1.14M | -$435,000.00 | -$135,000.00 | $110,000.00 | $110,000.00 |
| Receivables | – | – | $20.00M | – | – |
| -Accounts Receivable | – | – | $20.00M | – | – |
| Other Non-Current Liabilities | – | – | $388,000.00 | $1.09M | $1.09M |
| -Accumulated Depreciation | – | – | – | -$19.21M | -$19.21M |
| Convertible preferred securities | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$32.84M | -$15.05M | -$39.11M | -$111.94M | -$27.73M |
| Net cash flow from continuing operations | -$32.84M | -$15.05M | -$39.11M | -$111.94M | -$27.73M |
| Net Income from Continuing Operations | -$47.97M | -$44.73M | -$24.21M | -$131.12M | -$34.57M |
| Depreciation & Depletion & Amortization | $385,000.00 | $391,000.00 | $444,000.00 | $2.40M | $499,000.00 |
| Other Non-Cash Items | $878,000.00 | $972,000.00 | $1.22M | $2.65M | $577,000.00 |
| Change in Working Capital | $5.33M | $19.12M | -$23.68M | -$2.27M | -$311,000.00 |
| -Change in Prepaid Assets | $1.05M | -$1.94M | $404,000.00 | -$2.94M | -$433,000.00 |
| -Change in Payables and Accrued Expense | $5.02M | $2.18M | -$1.85M | $3.46M | $838,000.00 |
| -Change in Other Current Assets | $199,000.00 | $193,000.00 | -$605,000.00 | $537,000.00 | $163,000.00 |
| -Change in Other Current Liabilities | -$941,000.00 | -$1.32M | -$1.62M | -$3.32M | -$879,000.00 |
| Net cash flow from investing | -$31.41M | -$128.51M | $6.28M | -$170.96M | -$103.39M |
| Net Cash Flow from Continuing Investing Activities | -$31.41M | -$128.51M | $6.28M | -$170.96M | -$103.39M |
| Net PPE Purchase and Sale | -$288,000.00 | -$107,000.00 | -$93,000.00 | -$794,000.00 | -$34,000.00 |
| Net Investment Purchase and Sale | -$31.12M | -$128.40M | $6.37M | -$170.17M | -$103.35M |
| Financing Cash Flow | $15.77M | $147.44M | $42.36M | $275.34M | $3.59M |
| Net Cash Flow from Continuing Financing Activities | $15.77M | $147.44M | $42.36M | $275.34M | $3.59M |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $39.40M | $0.00 | $0.00 |
| Net Common Stock Issuance | $0.00 | $146.66M | $0.00 | $270.28M | -$2.29M |
| Proceeds from Stock Option Exercised | $1.17M | $1.70M | $4.08M | $5.56M | $3.43M |
| Net Other Financing Charges | $14.60M | -$917,000.00 | -$1.12M | -$500,000.00 | $2.45M |
| Ending Cash Balance | $155.24M | $203.73M | $199.85M | $190.34M | $190.34M |
| Net Change in Cash | -$48.49M | $3.88M | $9.52M | -$7.57M | -$127.53M |
| Beginning Cash Balance | $203.73M | $199.85M | $190.34M | $197.90M | $317.86M |
| Free Cash Flow | -$33.13M | -$15.16M | -$39.21M | -$112.73M | -$27.76M |
| -Change in Receivables | – | – | -$20.00M | – | – |
| Net Preferred Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on MAZE.
Sign in to join the discussion.